Latest News


Renal

Link between obesity severity and adverse outcomes for pregnant women and their babies.

There are calls for a greater focus on weight management following new research defining the relationship between obesity and pregnancy-related complications for mother and baby. The study follows an increase in obesity levels globally as well as a rise in prevalence during pregnancy. Today, more than 20 per cent of Australian women have obesity at the time of conception. Kolling Institu.....
Read more

Category: Research Excellence

The Kolling’s up and coming talent recognised .

Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Commi.....
Read more

Category: Awards

Recognition for a remarkable career.

Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice .....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Common, easily accessible medication could reduce severe COVID-19 symptoms.

A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, marking a significant breakthrough in the treatment of the virus. An exciting new study, involving researchers from across Australia and India, will investigate whether existing blood pressure medications can reduce the risk of severe disease as well as the duration of severe symptoms. Rese.....
Read more

Category: New Treatment